Search Results - "Lee, Chin H"

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1 by Mease, Philip J, van der Heijde, Désirée, Ritchlin, Christopher T, Okada, Masato, Cuchacovich, Raquel S, Shuler, Catherine L, Lin, Chen-Yen, Braun, Daniel K, Lee, Chin H, Gladman, Dafna D

“…To assess the safety and efficacy of ixekizumab, a monoclonal antibody that inhibits interleukin-17A, in a double-blind phase III trial enrolling patients with…”
Get more information

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate by Keystone, Edward C, Taylor, Peter C, Drescher, Edit, Schlichting, Douglas E, Beattie, Scott D, Berclaz, Pierre-Yves, Lee, Chin H, Fidelus-Gort, Rosanne K, Luchi, Monica E, Rooney, Terence P, Macias, William L, Genovese, Mark C

“…To investigate baricitinib (LY3009104, formerly INCB028050), a novel, oral inhibitor of JAK1/JAK2 in patients with moderate to severe rheumatoid arthritis (RA)…”
Get more information

Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1) by Gottlieb, Alice B, Strand, Vibeke, Kishimoto, Mitsumasa, Mease, Philip, Thaçi, Diamant, Birt, Julie, Lee, Chin H, Shuler, Catherine L, Lin, Chen-Yen, Gladman, Dafna D

“…Abstract Objective To report patient-reported outcomes of patients with PsA treated with ixekizumab up to 52 weeks. Methods In SPIRIT-P1, biologic-naïve…”
Get full text

Speech recognition employing keyword modeling and non-key word modeling by Lee, Chin H.

Get full text

A Potent, Orally Bioavailable Benzazepinone Growth Hormone Secretagogue by DeVita, Robert J, Bochis, Richard, Frontier, Alison J, Kotliar, Andrew, Fisher, Michael H, Schoen, William R, Wyvratt, Matthew J, Cheng, Kang, Chan, Wanda W.-S, Butler, Bridget, Jacks, Thomas M, Hickey, Gerard J, Schleim, Klaus D, Leung, Kwan, Chen, Zhesheng, Chiu, S.-H. Lee, Feeney, William P, Cunningham, Paul K, Smith, Roy G

“…The identification of L-739,943 (8b), a potent, orally bioavailable benzolactam growth hormone secretagogue, is obtained from zwitterionic L-692,429 through…”
Get full text

In vitro analysis of the TAT protein transduction domain as a drug delivery vehicle in protozoan parasites by Chin Lee, Stephanie Hui, Jefferies, Ryan, Watt, Paul, Hopkins, Richard, Sotzik, Frank, Reid, Simon, Armson, Anthony, Boxell, Annika, Ryan, Una

“…The present study was undertaken to analyse the capability of HIV-1 derived TAT protein transduction domain (PTD) fused with Green Fluorescent Protein…”
Get full text

Applications of dynamic programming to speech and language processing by Lee, Chin-Hui

“…Dynamic programming (DP) is a mathematical programming technique for solving certain sequential optimization problems. In this paper, we focus our discussion…”
Get full text

Subword-based large-vocabulary speech recognition by Lee, Chin-Hui, Gauvain, Jean-Luc, Pieraccini, Roberto, Rabiner, Lawrence R.

“…During the past several years, research in large-vocabulary speech recognition has been intensively carried out worldwide, encouraged by advances in…”
Get full text